No glycemic benefit from guar administration in NIDDM.
A randomized crossover study of 5-g guar minitablets against placebo, given three times per day with main meals for 8 wk, was done in 29 non-insulin-dependent diabetes mellitus (NIDDM) patients who had near-normal fasting plasma glucose concentrations on treatment with diet alone, additional sulfony...
Hauptverfasser: | Holman, R, Steemson, J, Darling, P, Turner, R |
---|---|
Format: | Journal article |
Sprache: | English |
Veröffentlicht: |
1987
|
Ähnliche Einträge
Ähnliche Einträge
-
LACK OF BENEFIT FROM GUAR ADMINISTRATION IN WELL CONTROLLED NON-INSULIN-DEPENDENT DIABETIC-PATIENTS
von: Holman, R, et al.
Veröffentlicht: (1984) -
Insulin use in NIDDM. Rationale based on pathophysiology of disease.
von: Turner, R, et al.
Veröffentlicht: (1990) -
Treatment of NIDDM - Progressive requirement for polypharmacy to attain glycaemic goals
von: Cull, C, et al.
Veröffentlicht: (1997) -
Effects of ethnicity on metabolic control during the first six years of NIDDM
von: Davis, T, et al.
Veröffentlicht: (1997) -
Coronary heart disease and risk factors in NIDDM--experience from the United Kingdom Prospective Diabetes Study.
von: Turner, R, et al.
Veröffentlicht: (1997)